|
2025
|
Invention
|
Methods of treatment using a bispecific antigen-binding construct targeting her2.
Described here... |
|
|
Invention
|
Antibody-drug conjugates targeting folate receptor alpha and methods of use.
Antibody-drug conju... |
|
|
Invention
|
Trivalent and trispecific antibody constructs and methods of use thereof.
The present disclosure... |
|
|
Invention
|
Antibody-drug conjugates targeting glypican-3 and methods of use.
Described herein are antibody-... |
|
|
Invention
|
Antibody-drug conjugates targeting napi2b and methods of use.
Described herein are antibody-drug... |
|
|
Invention
|
Anti-napi2b antibodies and methods of use.
Described herein are antibody constructs that bind hu... |
|
|
Invention
|
Antibody drug-conjugates targeting c-met and methods of use thereof.
Antibody-drug conjugates (A... |
|
|
Invention
|
Multispecific and costimulatory antibody constructs and methods of use thereof. The present discl... |
|
|
Invention
|
Antibody constructs binding folate receptor alpha and napi2b, conjugates and methods of use. Bisp... |
|
|
Invention
|
Trispecific antibody constructs targeting dll3 and methods of use thereof. The present disclosure... |
|
|
Invention
|
Immunomodulator purine-derived compounds, conjugates thereof, and methods of use thereof.
Purine... |
|
|
Invention
|
Modified antigen bindingpolypeptide constructs and uses thereof.
The present invention provides ... |
|
2024
|
Invention
|
Bispecific antigen binding constructs targeting her2.
Provided herein are biparatopic antigen-bi... |
|
|
Invention
|
Methods of using bispecific antigen-binding constructs targeting her2.
Described herein methods ... |
|
|
Invention
|
Anti-napi2b antibody-drug conjugates and methods of use. Described herein are anti-NaPi2b antibod... |
|
|
G/S
|
Pharmaceutical preparations for regulating the immune system, antibodies, antibody-drug conjugate... |
|
|
Invention
|
Stable heterodimeric antibody design with mutations in the fc domain.
The provided scaffolds hav... |
|
|
Invention
|
Immunomodulatory trispecific t cell engager fusion proteins.
The present disclosure provides fus... |
|
|
Invention
|
Methods of using a bispecific antigen-binding construct targeting her2 in combination with cdk4/6... |
|
|
Invention
|
Multivalent and bispecific antibody constructs and methods of use thereof. The present disclosure... |
|
|
Invention
|
Antibody-drug conjugates targeting folate receptor alpha and methods of use. Antibody-drug conjug... |
|
|
Invention
|
Bis-intercalating peptides, conjugates and methods of use.
Bis-intercalating peptide compounds h... |
|
|
Invention
|
Modified interleukin p40 subunit proteins and methods of use thereof.
This disclosure generally ... |
|
|
Invention
|
Bispecific asymmetric heterodimers comprising anti-cd3 constructs.
Disclosed herein are isolated... |
|
|
Invention
|
Multivalent polypeptide constructs capable of binding viral spike proteins and methods of using t... |
|
|
Invention
|
Fc variant with high thermal stability and attenuated effector function.
A polypeptide comprisin... |
|
|
G/S
|
Scientific research and development of preparations, agents and technology for the development of... |
|
2023
|
Invention
|
Anti-napi2b antibodies and methods of use |
|
|
Invention
|
Antibody-drug conjugates targeting napi2b and methods of use |
|
|
Invention
|
Trivalent and trispecific antibody constructs and methods of use thereof |
|
|
Invention
|
Anti-napi2b antibodies and methods of use. Described herein are antibody constructs that bind hum... |
|
|
Invention
|
Antibody-drug conjugates targeting napi2b and methods of use. Described herein are antibody-drug ... |
|
|
Invention
|
Trivalent and trispecific antibody constructs and methods of use thereof. The present disclosure ... |
|
|
Invention
|
Antibody-drug conjugates targeting glypican-3 and methods of use. Described herein are antibody-d... |
|
|
Invention
|
Antibody-drug conjugates targeting glypican-3 and methods of use |
|
|
Invention
|
Antibody drug conjugates targeting c-met and methods of use |
|
|
Invention
|
Antibody drug conjugates targeting c-met and methods of use. Antibody-drug conjugates (ADCs) comp... |
|
|
G/S
|
Chemical, biochemical and biological research and analysis; biotechnological research and develop... |
|
|
Invention
|
Multivalent and bispecific antibody constructs and methods of use thereof |
|
|
Invention
|
Immunomodulator purine-derived compounds, conjugates thereof, and methods of use thereof. Disclos... |
|
2022
|
Invention
|
Systems and methods for polymer side-chain conformation prediction.
Disclosed systems and method... |
|
|
Invention
|
Systems and methods for polymer sequence prediction.
Systems and methods for polymer sequence pr... |
|
|
Invention
|
Methods of treating cancer with anti-her2 biparatopic antibodies.
Methods of treating subjects h... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in o... |
|
|
Invention
|
Camptothecin analogues, conjugates and methods of use.
Camptothecin analogues of Formula (I) and... |
|
2021
|
Invention
|
Stabilized tcr constructs and methods of use.
Stabilized TCR constructs comprising a TCR alpha c... |
|
|
Invention
|
Imidazothienopyridine compounds and methods of use.
Disclosed herein are compounds having Formul... |
|
|
Invention
|
Heterodimeric iga fc constructs and methods of use thereof.
Heterodimeric IgA Fc (IgA HetFc) con... |
|
|
Invention
|
Heterodimeric fc variants selective for fc gamma riib.
Heterodimeric Fc variants comprising one ... |
|
2019
|
Invention
|
Antibody constructs binding 4-1bb and tumor-associated antigens and uses thereof |
|
|
Invention
|
Methods of using a bispecific antigen-binding construct targeting her2 for the treatment of gastr... |
|
2016
|
G/S
|
Chemical preparations for use in the manufacture of pharmaceuticals |
|
|
Invention
|
Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereof.... |
|
2015
|
Invention
|
Modified antigen binding polypeptide constructs and uses thereof |
|
2013
|
G/S
|
Therapeutic, prophylactic preparations, and pharmaceutical preparations and agents for the treatm... |
|
2009
|
G/S
|
Chemical molecular analysis and product optimization, namely, product research and development fo... |
